Review



single cell tracks  (Oxford Instruments)


Bioz Verified Symbol Oxford Instruments is a verified supplier
Bioz Manufacturer Symbol Oxford Instruments manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Oxford Instruments single cell tracks
    Single Cell Tracks, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 41025 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single cell tracks/product/Oxford Instruments
    Average 99 stars, based on 41025 article reviews
    single cell tracks - by Bioz Stars, 2026-04
    99/100 stars

    Images



    Similar Products

    99
    Oxford Instruments single cell tracks
    Single Cell Tracks, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single cell tracks/product/Oxford Instruments
    Average 99 stars, based on 1 article reviews
    single cell tracks - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    Sartorius AG cell tracking assays
    Cell Tracking Assays, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell tracking assays/product/Sartorius AG
    Average 99 stars, based on 1 article reviews
    cell tracking assays - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    90
    Schmid GmbH robust single-particle tracking in live-cell time-lapse sequences
    Robust Single Particle Tracking In Live Cell Time Lapse Sequences, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/robust single-particle tracking in live-cell time-lapse sequences/product/Schmid GmbH
    Average 90 stars, based on 1 article reviews
    robust single-particle tracking in live-cell time-lapse sequences - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    MathWorks Inc single cell tracking algorithm
    Single Cell Tracking Algorithm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single cell tracking algorithm/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    single cell tracking algorithm - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    96
    Nikon cell inclusion survival tracking
    (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type <t>inclusion</t> in the same <t>cell.</t> White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal <t>single-inclusion</t> and single-cell <t>survival</t> <t>tracking.</t> Log rank test: **** p < 0.0001. Error bars = SD.
    Cell Inclusion Survival Tracking, supplied by Nikon, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell inclusion survival tracking/product/Nikon
    Average 96 stars, based on 1 article reviews
    cell inclusion survival tracking - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    Wieser GmbH tracking single molecules in the live cell plasma membrane-do’s and don’t’s
    (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type <t>inclusion</t> in the same <t>cell.</t> White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal <t>single-inclusion</t> and single-cell <t>survival</t> <t>tracking.</t> Log rank test: **** p < 0.0001. Error bars = SD.
    Tracking Single Molecules In The Live Cell Plasma Membrane Do’s And Don’t’s, supplied by Wieser GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tracking single molecules in the live cell plasma membrane-do’s and don’t’s/product/Wieser GmbH
    Average 90 stars, based on 1 article reviews
    tracking single molecules in the live cell plasma membrane-do’s and don’t’s - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Mendeley Ltd dataset for single-cell tracking as a tool for studying emt-phenotypes
    (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type <t>inclusion</t> in the same <t>cell.</t> White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal <t>single-inclusion</t> and single-cell <t>survival</t> <t>tracking.</t> Log rank test: **** p < 0.0001. Error bars = SD.
    Dataset For Single Cell Tracking As A Tool For Studying Emt Phenotypes, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dataset for single-cell tracking as a tool for studying emt-phenotypes/product/Mendeley Ltd
    Average 90 stars, based on 1 article reviews
    dataset for single-cell tracking as a tool for studying emt-phenotypes - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    MathWorks Inc custom single-cell tracking algorithm
    (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type <t>inclusion</t> in the same <t>cell.</t> White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal <t>single-inclusion</t> and single-cell <t>survival</t> <t>tracking.</t> Log rank test: **** p < 0.0001. Error bars = SD.
    Custom Single Cell Tracking Algorithm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom single-cell tracking algorithm/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    custom single-cell tracking algorithm - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type inclusion in the same cell. White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal single-inclusion and single-cell survival tracking. Log rank test: **** p < 0.0001. Error bars = SD.

    Journal: Neuron

    Article Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

    doi: 10.1016/j.neuron.2024.06.002

    Figure Lengend Snippet: (A) Top, time-lapse imaging of LipidSpot(+) inclusions pre- (T = 0 min) and post-treatment (T = 60 min) with DMSO or trifluoperazine. Bottom, quantification of LipidSpot(+), LipidSpot(−) neurite-type, or soma-type inclusions at T = 60 min post-treatment (3 independent replicates per condition, reproduced across 3 neuronal differentiations using the highest treatment concentrations). (B) Time-lapse imaging in seeded PFF model capturing interaction between LipidSpot(+) inclusions and elongating neurite-type inclusion in the same cell. White arrow, neurite-type inclusion (GFP(+)/LipidSpot(−)). Inset, cell soma with two GFP(+)/LipidSpot(+) inclusions (DIV20), which become one GFP(+)/LipidSpot(−) inclusion (DIV29). (C) Confocal image of adjacent LipidSpot(+) and LipidSpot(−) inclusions. (D) Dynamic lattice light-sheet microscopy (3D rendering) of a LipidSpot(+)/GFP(+) soma-type inclusion. White arrows, small αS-sfGFP aggregates; pink arrowheads, sequestered lipid accumulations; pink arrow, lipid aggregate partially internalized into the inclusion. (E) pS129 and neurofilament IF in sporadic PD brain (frontal cortex) shows soma-type inclusion reminiscent of fusion examples in (B)–(D). (F) CLEM example of αS(+) inclusions with mixed amyloid and lipid pathology in substantia nigra of sporadic PD brain (top) and seeded inclusionopathy model (bottom). (G) Manual longitudinal single-inclusion and single-cell survival tracking. Log rank test: **** p < 0.0001. Error bars = SD.

    Article Snippet: We developed algorithms for single-cell inclusion survival tracking with longitudinal imaging (BioStation CT, Nikon) for both spontaneous and seeded inclusionopathy models ( – ).

    Techniques: Imaging, Microscopy

    (A) Schematic of spontaneous inclusionopathy model. (B) Left, pS129 IF in pi-Ns overexpressing sfGFP-tagged or untagged αS-3K, untagged αS-WT, or sfGFP control. Right, quantification of IF. One-way ANOVA plus Tukey’s multiple comparison test: **** p < 0.0001; ns, not significant. (C) Western blot after sequential TX-100/SDS extraction of soluble and insoluble protein fractions. (D) CLEM for αS-pS129 (leftmost 3 panels) and LipidSpot labeling (right 2 panels) in spontaneous inclusionopathy model. (E) Immunoreactivity profiles of soma-type inclusions in pi-N 3K-sfGFP-pB model. Total number of inclusions counted shown in parentheses. (F) Inclusion subtype classification in spontaneous inclusionopathy model. (G) Inclusion survival tracking in spontaneous inclusionopathy model. Examples of GFP(+)/RFP(+) neurons detected in the BioStation CT. (H) Experimental time line for BioStation CT imaging. (I) Example of automated mask for soma-type inclusions. Neuron was identified as dead at the 90 h time point. (J) Kaplan-Meier curve comparing survival probabilities of pi-N 3K-sfGFP-pB model with and without inclusions and pi-N sfGFP-pB control neurons. Log rank test: * p < 0.05, *** p < 0.001, **** p < 0.0001. Data are representative of 3 separate neuronal differentiations. Error bars in (B) = SD.

    Journal: Neuron

    Article Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

    doi: 10.1016/j.neuron.2024.06.002

    Figure Lengend Snippet: (A) Schematic of spontaneous inclusionopathy model. (B) Left, pS129 IF in pi-Ns overexpressing sfGFP-tagged or untagged αS-3K, untagged αS-WT, or sfGFP control. Right, quantification of IF. One-way ANOVA plus Tukey’s multiple comparison test: **** p < 0.0001; ns, not significant. (C) Western blot after sequential TX-100/SDS extraction of soluble and insoluble protein fractions. (D) CLEM for αS-pS129 (leftmost 3 panels) and LipidSpot labeling (right 2 panels) in spontaneous inclusionopathy model. (E) Immunoreactivity profiles of soma-type inclusions in pi-N 3K-sfGFP-pB model. Total number of inclusions counted shown in parentheses. (F) Inclusion subtype classification in spontaneous inclusionopathy model. (G) Inclusion survival tracking in spontaneous inclusionopathy model. Examples of GFP(+)/RFP(+) neurons detected in the BioStation CT. (H) Experimental time line for BioStation CT imaging. (I) Example of automated mask for soma-type inclusions. Neuron was identified as dead at the 90 h time point. (J) Kaplan-Meier curve comparing survival probabilities of pi-N 3K-sfGFP-pB model with and without inclusions and pi-N sfGFP-pB control neurons. Log rank test: * p < 0.05, *** p < 0.001, **** p < 0.0001. Data are representative of 3 separate neuronal differentiations. Error bars in (B) = SD.

    Article Snippet: We developed algorithms for single-cell inclusion survival tracking with longitudinal imaging (BioStation CT, Nikon) for both spontaneous and seeded inclusionopathy models ( – ).

    Techniques: Control, Comparison, Western Blot, Extraction, Labeling, Imaging

    (A) Cartoon of U2OS model harboring pB-SNCA-3K-sfGFP transgene. Micrographs show transgene GFP signal in doxycycline-treated cells. (B) Genome-wide CRISPR-Cas9 knockout screen for modifiers of αS toxicity. (C) Volcano plot showing depletion of essential genes (blue). (D) Volcano plot comparing fold-change differential between SNCA-3K-sfGFP and SNCA-WT-sfGFP genotypes. (E) Overlap between spatial (APEX2 and MYTH) and genetic (CRISPR) screen hits. (F) Interaction of actin cytoskeleton-related proteins RhoA and RhoBTB3 with αS by MYTH. (G) Left, Kaplan-Meier curve of single-cell survival tracking in pi-N 3K-sfGFP-pB and pi-N sfGFP-pB models transduced with shRNA lentivirus. Log rank test: *** p < 0.001, **** p < 0.0001. Data are representative of 2 neuronal differentiations with shRNA lentivirus at MOI20. Right, neurite measurement based on RFP signal. (H) PLA of RhoA-pS129 in inclusionopathy models. Bottom, quantification of pS129(+) soma-type inclusions from 3 to 4 independent replicates across 3 separate neuronal differentiations. One-way ANOVA plus Tukey’s multiple comparison test: **** p < 0.0001; n.s., not significant. (I) IF for RhoA, p62, and αS in A53T ( n = 2), E46K ( n = 2), and sporadic ( n = 11) PD brain. Orange arrow, αS(+)/p62(+)/RhoA(+) inclusion; white arrow, αS(+)/p62(+)/RhoA(−) inclusion. (J) Left, quantification of pS129(+)/RhoA(+) inclusions in PD brain. Right, quantification of (I). Error bars = SD.

    Journal: Neuron

    Article Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

    doi: 10.1016/j.neuron.2024.06.002

    Figure Lengend Snippet: (A) Cartoon of U2OS model harboring pB-SNCA-3K-sfGFP transgene. Micrographs show transgene GFP signal in doxycycline-treated cells. (B) Genome-wide CRISPR-Cas9 knockout screen for modifiers of αS toxicity. (C) Volcano plot showing depletion of essential genes (blue). (D) Volcano plot comparing fold-change differential between SNCA-3K-sfGFP and SNCA-WT-sfGFP genotypes. (E) Overlap between spatial (APEX2 and MYTH) and genetic (CRISPR) screen hits. (F) Interaction of actin cytoskeleton-related proteins RhoA and RhoBTB3 with αS by MYTH. (G) Left, Kaplan-Meier curve of single-cell survival tracking in pi-N 3K-sfGFP-pB and pi-N sfGFP-pB models transduced with shRNA lentivirus. Log rank test: *** p < 0.001, **** p < 0.0001. Data are representative of 2 neuronal differentiations with shRNA lentivirus at MOI20. Right, neurite measurement based on RFP signal. (H) PLA of RhoA-pS129 in inclusionopathy models. Bottom, quantification of pS129(+) soma-type inclusions from 3 to 4 independent replicates across 3 separate neuronal differentiations. One-way ANOVA plus Tukey’s multiple comparison test: **** p < 0.0001; n.s., not significant. (I) IF for RhoA, p62, and αS in A53T ( n = 2), E46K ( n = 2), and sporadic ( n = 11) PD brain. Orange arrow, αS(+)/p62(+)/RhoA(+) inclusion; white arrow, αS(+)/p62(+)/RhoA(−) inclusion. (J) Left, quantification of pS129(+)/RhoA(+) inclusions in PD brain. Right, quantification of (I). Error bars = SD.

    Article Snippet: We developed algorithms for single-cell inclusion survival tracking with longitudinal imaging (BioStation CT, Nikon) for both spontaneous and seeded inclusionopathy models ( – ).

    Techniques: Genome Wide, CRISPR, Knock-Out, Transduction, shRNA, Comparison